HENDERSON, Nev. – June 11, 2025 – (Business Wire)– Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the… Read more »
Our guest post, “Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability,” is featured on Drug Channels, popular among industry insiders and outsiders for their expert insights and straightforward explanations of pharmaceutical economics and the drug distribution system. This article written by our VP of Patient Affordability explores how traditional copay assistance models… Read more »
The Additions Significantly Increase the Company’s U.S. Plasma Market Share HENDERSON, Nev. – June 5, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has been awarded 132 established plasma donation centers through an expansion of… Read more »
HENDERSON, Nev. – May 29, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced its CFO, Jeff Baker, will be attending and presenting at the MicroCap Rodeo Spring Conference in New York City on Wednesday,… Read more »
Our article, “Cracking the Code on Copay – From Mitigation to Mastery” by Bryan Dennison, MBA, Senior VP of Sales and Products, is featured in PM360, the essential resource for pharmaceutical marketers, May 2025 issue. This Expert on Call article is our fourth submission, which further explains how innovative copay solution providers are transforming the pharmaceutical… Read more »
HENDERSON, Nev. – May 8, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the first quarter 2025. “Q1 2025 was another exceptional quarter for Paysign, as we achieved record revenue, operating… Read more »
HENDERSON, Nev. – April 22, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss first quarter 2025 earnings at 5:00 p.m. ET on Thursday, May 8, 2025. Participant details are as follows: U.S. dial-in: 800.579.2543… Read more »
Paysign is excited to once again be a sponsor at the Plasma Protein Therapeutics Association 2025 International Plasma Protein Congress held on May 20-21 in Warsaw, Poland. This conference will explore the plasma industry, the need to increase plasma collection, patient health, safety, and the developments within regulatory and policy categories.
HENDERSON, Nev. – April 9, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced its CFO, Jeff Baker, will be attending and presenting at the Ladenburg Thalmann Technology Innovation EXPO25 in New York City on… Read more »
Paysign will be a sponsor at the annual Innovative Payments Conference, “Making Sense of Payments in a Changing World” in Washington, D.C. on April 29 – May 01, 2025. This 3-day conference will consist of revolutionary content, discussions, and networking opportunities with those leading the way in payments compliance, legislation, regulation, and innovation.
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.